Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CorNeat Vision

Explore full profile

Permanent Tissue-Integrating Implants

Ra'anana, IsraelFounded 2015Health Tech & Medtech
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CorNeat Vision and the history behind them.

About CorNeat Vision

CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, CorNeat EverMatrix™, overcomes the main issue with implants and implantables – the foreign body response they trigger.

The EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants.

The EverMatrix™ is set to displace harvested and processed human and animal tissues, including scaffolds and extra cellular matrices, used in a variety of surgical procedures across diversified fields of medicine.

CorNeat KPro: The CorNeat KPro is a novel self-integrating artificial cornea solution that enables corneally blind patients to regain sight and fully enjoy their vision potential without relying on donor tissue. The implant leverages a synthetic, tissue-integrating and biomimetic skirt and a straightforward surgical procedure, hence can scale globally to address the acute global shortage in donor tissue.

CorNeat EverPatch: The FDA cleared CorNeat EverPatch is the first non-degradable synthetic tissue substitute for ophthalmic surgery. It eliminates the need for scleral patches and processed tissue patches used in a variety of ophthalmic procedures.

CorNeat eShunt: The CorNeat eShunt is a tissue-integrating glaucoma drainage device that extends minimally invasive surgery to severe and refractory glaucoma patients. Unlike the current standard of care, the CorNeat eShunt’s patented drainage mechanism and drainage site are designed to provide predictable pressure reduction with enduring efficacy, while reducing the risk of hypotony.

CorNeat gPatch: The CorNeat gPatch is the only permanent membrane for gingival tissue reinforcement and guided tissue and bone regeneration. The CorNeat gPatch presents a paradigm shift in periodontology, as it also addresses long term complications around implants by providing a robust infrastructure for gum tissue.

Source: Dealroom company data

At a glance

Founded
2015
Headquarters
Ra'anana, Israel
Sector
Health Tech & Medtech

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇮🇱 Israel35.7%
🇺🇸 United States14.3%
🇬🇧 United Kingdom7.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CorNeat Vision on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CorNeat Vision on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.